1TB6 - JenaLib

Asymmetric Unit (36, 36)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	LEU H:60 , ASN H:60G , NAG H:779 , FUC H:780	BINDING SITE FOR RESIDUE NDG H 778
02	AC2	SOFTWARE	NDG H:778 , FUC H:780	BINDING SITE FOR RESIDUE NAG H 779
03	AC3	SOFTWARE	NDG H:778 , NAG H:779	BINDING SITE FOR RESIDUE FUC H 780
04	AC4	SOFTWARE	TRP H:147A , ARG H:221A , ASN I:233 , ARG I:235 , TYR I:253 , HOH I:955	BINDING SITE FOR RESIDUE MPD H 781
05	AC5	SOFTWARE	ILE H:24 , GLY H:25 , SER H:27 , GLY H:69 , LYS H:70 , HIS H:71 , TYR H:117 , LEU H:155	BINDING SITE FOR RESIDUE MPD H 782
06	AC6	SOFTWARE	ARG H:67 , LYS H:70 , THR H:74 , TYR H:76 , GLU H:80 , LEU I:210	BINDING SITE FOR RESIDUE MPD H 783
07	AC7	SOFTWARE	LEU H:130 , ALA H:132 , VAL H:163 , ARG H:165 , PHE H:181	BINDING SITE FOR RESIDUE MPD H 784
08	AC8	SOFTWARE	THR H:147B , ALA H:147C , ARG H:233 , LYS H:236 , LYS I:403 , GU6 I:434	BINDING SITE FOR RESIDUE GU4 I 433
09	AC9	SOFTWARE	ARG H:93 , ARG H:101 , THR H:147B , LYS H:149 , LYS H:236 , HOH H:802 , LYS I:403 , GU4 I:433 , GU0 I:435 , HOH I:881 , HOH I:904	BINDING SITE FOR RESIDUE GU6 I 434
10	BC1	SOFTWARE	PRO H:92 , ARG H:93 , LYS H:145 , GLU H:146 , THR H:147 , TRP H:147A , THR H:147B , LYS H:149 , GU6 I:434 , GU5 I:436 , GU8 I:437	BINDING SITE FOR RESIDUE GU0 I 435
11	BC2	SOFTWARE	LYS H:145 , TRP H:147A , ARG I:235 , GU0 I:435 , GU8 I:437 , HOH I:944 , HOH I:963	BINDING SITE FOR RESIDUE GU5 I 436
12	BC3	SOFTWARE	ARG H:187 , GU0 I:435 , GU5 I:436 , GU9 I:438	BINDING SITE FOR RESIDUE GU8 I 437
13	BC4	SOFTWARE	GLU H:18 , GU8 I:437 , GU8 I:439	BINDING SITE FOR RESIDUE GU9 I 438
14	BC5	SOFTWARE	ARG H:187 , GU9 I:438 , GU9 I:440	BINDING SITE FOR RESIDUE GU8 I 439
15	BC6	SOFTWARE	GU8 I:439 , GU8 I:441	BINDING SITE FOR RESIDUE GU9 I 440
16	BC7	SOFTWARE	GU9 I:440 , GU9 I:442	BINDING SITE FOR RESIDUE GU8 I 441
17	BC8	SOFTWARE	GU8 I:441 , GU8 I:443	BINDING SITE FOR RESIDUE GU9 I 442
18	BC9	SOFTWARE	GU9 I:442 , GU5 I:444	BINDING SITE FOR RESIDUE GU8 I 443
19	CC1	SOFTWARE	ALA I:43 , THR I:44 , ASN I:45 , VAL I:48 , ARG I:129 , GU8 I:443 , GU1 I:445 , HOH I:945	BINDING SITE FOR RESIDUE GU5 I 444
20	CC2	SOFTWARE	LYS I:11 , ASN I:45 , ARG I:46 , LYS I:125 , GU5 I:444 , GU6 I:446 , ARG L:1I	BINDING SITE FOR RESIDUE GU1 I 445
21	CC3	SOFTWARE	ARG H:50 , LYS I:11 , PRO I:12 , ARG I:13 , ASN I:45 , LYS I:114 , LYS I:125 , GU1 I:445 , GU2 I:447 , ARG L:1I	BINDING SITE FOR RESIDUE GU6 I 446
22	CC4	SOFTWARE	GLU H:86 , ARG I:46 , ARG I:47 , LYS I:114 , GU6 I:446 , GU3 I:448	BINDING SITE FOR RESIDUE GU2 I 447
23	CC5	SOFTWARE	ARG I:47 , SER I:112 , GLU I:113 , LYS I:114 , GU2 I:447	BINDING SITE FOR RESIDUE GU3 I 448
24	CC6	SOFTWARE	ASN I:96	BINDING SITE FOR RESIDUE NDG I 801
25	CC7	SOFTWARE	ASN I:18 , MET I:20 , ASN I:155 , THR I:157 , PRO I:352 , VAL I:355 , NAG I:842	BINDING SITE FOR RESIDUE NAG I 841
26	CC8	SOFTWARE	PRO I:16 , ASN I:18 , PRO I:19 , MET I:20 , THR I:157 , NAG I:841 , BMA I:843	BINDING SITE FOR RESIDUE NAG I 842
27	CC9	SOFTWARE	NAG I:842 , MAN I:844 , MAN I:845	BINDING SITE FOR RESIDUE BMA I 843
28	DC1	SOFTWARE	BMA I:843	BINDING SITE FOR RESIDUE MAN I 844
29	DC2	SOFTWARE	BMA I:843	BINDING SITE FOR RESIDUE MAN I 845
30	DC3	SOFTWARE	ASN I:192 , NAG I:862	BINDING SITE FOR RESIDUE NAG I 861
31	DC4	SOFTWARE	NAG I:861 , BMA I:863	BINDING SITE FOR RESIDUE NAG I 862
32	DC5	SOFTWARE	NAG I:862	BINDING SITE FOR RESIDUE BMA I 863
33	DC6	SOFTWARE	ASN I:127 , TYR I:131 , LEU I:140 , SER I:142 , MPD I:866	BINDING SITE FOR RESIDUE MPD I 864
34	DC7	SOFTWARE	THR I:60 , GLN I:64 , GLU I:296 , LEU I:299 , THR I:300 , PRO I:301 , PHE I:411 , MET I:423	BINDING SITE FOR RESIDUE MPD I 865
35	DC8	SOFTWARE	VAL I:165 , TYR I:166 , GLY I:167 , MPD I:864 , HOH I:885	BINDING SITE FOR RESIDUE MPD I 866
36	DC9	SOFTWARE	SER H:36A , PRO H:37 , PRO I:203 , ALA I:206 , SER I:330 , ASP I:366 , PHE I:368	BINDING SITE FOR RESIDUE MPD I 867

SS Bonds (8, 8)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (90, 90)

Asymmetric/Biological Unit (90, 90)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	I	I	7	N
02	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	I	M	20	T
03	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	I	C	21	F
04	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	I	R	24	C
05	UniProt	VAR_006714	M	380	T	THRB_HUMAN	Disease (FA2D)	121918481	H	M	32	T
06	UniProt	VAR_011782	P	386	T	THRB_HUMAN	Polymorphism	5897	H	P	37	T
07	UniProt	VAR_007036	P	73	L	ANT3_HUMAN	Disease (AT3D)	121909551	I	P	41	L
08	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	I	R	47	C
09	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	I	R	47	H
10	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	I	R	47	S
11	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	I	R	57	C
12	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	58	L
13	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	I	Y	63	C
14	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	I	Y	63	S
15	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	66	P
16	UniProt	VAR_006715	R	425	C	THRB_HUMAN	Disease (FA2D)	121918479	H	R	67	C
17	UniProt	VAR_006716	R	431	H	THRB_HUMAN	Disease (FA2D)	121918482	H	R	73	H
18	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	I	P	80	T
19	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	I	M	89	K
20	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	I	G	93	D
21	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	I	C	95	R
22	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	I	L	99	F
23	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	I	L	99	V
24	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	I	Q	101	K
25	UniProt	VAR_006717	R	461	W	THRB_HUMAN	Disease (FA2D)	121918478	H	R	101	W
26	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	I	K	114	E
27	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	I	T	115	A
28	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	I	S	116	P
29	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	I	Q	118	P
30	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	I	H	120	Y
31	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	126	P
32	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	I	C	128	Y
33	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	I	R	129	Q
34	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	I	N	135	T
35	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	138	P
36	UniProt	VAR_006718	E	509	A	THRB_HUMAN	Disease (FA2D)	---	H	E	146	A
37	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	I	L	146	H
38	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	147	L
39	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	I	Y	158	C
40	UniProt	VAR_068913	E	532	Q	THRB_HUMAN	Polymorphism	---	H	E	164	Q
41	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	I	Y	166	C
42	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	I	Y	166	H
43	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	I	S	182	F
44	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	I	S	182	Y
45	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	I	I	186	N
46	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	I	N	187	D
47	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	I	N	187	K
48	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	I	S	191	P
49	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	I	T	211	I
50	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	I	V	216	G
51	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	I	I	219	T
52	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	I	W	225	R
53	UniProt	VAR_006719	G	601	V	THRB_HUMAN	Disease (FA2D)	121918480	H	G	226	V
54	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	229	L
55	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	I	E	237	K
56	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	I	M	251	I
57	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	I	M	251	V
58	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	I	R	261	P
59	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	270	P
60	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	I	I	284	N
61	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	291	P
62	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	I	E	302	K
63	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	I	S	349	P
64	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	I	R	359	Q
65	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	365	P
66	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	I	D	366	H
67	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	I	H	369	R
68	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	I	A	387	V
69	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	I	G	392	D
70	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	I	R	393	C
71	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	I	R	393	H
72	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	I	R	393	P
73	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	I	S	394	L
74	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	C
75	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	L
76	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	S
77	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	I	A	404	T
78	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	I	N	405	K
79	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	I	R	406	G
80	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	I	R	406	M
81	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	I	P	407	A
82	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	I	P	407	L
83	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	I	P	407	T
84	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	409	P
85	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	I	I	421	T
86	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	I	G	424	R
87	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	I	R	425	T
88	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	I	A	427	D
89	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	I	P	429	L
90	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	I	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (4, 4)

Exons (13, 14)

Sequences/Alignments

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain H from PDB  Type:PROTEIN  Length:259
 aligned with THRB_HUMAN | P00734 from UniProtKB/Swiss-Prot  Length:622

    Alignment length:259
                                   373       383       393       403       413       423       433       443       453       463       473       483       493       503       513       523       533       543       553       563       573       583       593       603       613         
          THRB_HUMAN    364 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE  622
               SCOP domains d1tb6.1 L:,H: Thrombin                                                                                                                                                                                                                                              SCOP domains
               CATH domains 1tb6H01     1tb6H02 H:28-120,H:233-245 Trypsin-like serine proteases                                                 1tb6H01 H:16-27,H:121-232 Trypsin-like serine proteases                                                                        1tb6H02      -- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....ee........eeeeee....eeeeeeee....eeeehhhh.eehhhhee.hhh.eeeee.............eee.eeeeee..............eeeee................hhhhhhhhh....eeeeee....................eeeeee..hhhhhhhhh.......eeee..hhhhh............eeeee......eeeeeeeee..........eeeee...hhhhhhhhhhhhh. Sec.struct. author
                 SAPs(SNPs) ----------------T-----T--------------------------------------C-----H-----------------------------W-----------------------------------------------A----------------------Q--------------------------------------------------------------------V--------------------- SAPs(SNPs)
                PROSITE (1) TRYPSIN_DOM  PDB: H:16-243 UniProt: 364-618                                                                                                                                                                                                                    ---- PROSITE (1)
                PROSITE (2) --------------------------------------TRYPSI----------------------------------------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER ------------------------------------------------- PROSITE (2)
           Transcript 1 (1) -------------Exon 1.10  PDB: H:29-75 UniProt: 377-433                 ---------------------------------------------------------Exon 1.12  PDB: H:129B-184 UniProt: 491-552                   -----------------------Exon 1.14c  PDB: H:203-247 (gaps)               Transcript 1 (1)
           Transcript 1 (2) Exon 1.9      -------------------------------------------------------Exon 1.11b  PDB: H:75-129B UniProt: 433-491                ------------------------------------------------------------Exon 1.13  PDB: H:184-20----------------------------------------------- Transcript 1 (2)
                1tb6 H   16 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE  247
                                    25        35 |      44        54      |60D|||||   65        75  |     84        94   |   103       113       123      |130       140      147C||     155       165       175      184A  |||| 190       200    || 208       219  |    228       238         
                                               36A                      60A||||||||               77A                  97A                             129A||               147A||||                                  184A  ||||               204A|          217|  |                          
                                                                         60B|||||||                                                                     129B|                147B|||                                     186A|||                204B           219  |                          
                                                                          60C||||||                                                                      129C                 147C||                                      186B||                                 221A                          
                                                                           60D|||||                                                                                            147D|                                       186C|                                                               
                                                                            60E||||                                                                                             147E                                        186D                                                               
                                                                             60F|||                                                                                                                                                                                                            
                                                                              60G||                                                                                                                                                                                                            
                                                                               60H|                                                                                                                                                                                                            
                                                                                60I

Chain I from PDB  Type:PROTEIN  Length:412
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:428
                                    45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315       325       335       345       355       365       375       385       395       405       415       425       435       445       455        
          ANT3_HUMAN     36 PVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV  463
               SCOP domains d1tb6i_ I: Antithrombin                                                                                                                                                                                                                                                                                                                                                                                                                      SCOP domains
               CATH domains --------1tb6I02 I:12-22          4,I:321-377 Antithrombin, subunit I, domain 2                                                                                                                                               1tb6I01 I:225-320,I:386-429 Alpha-1-antitrypsin, domain 1                                       1tb6I02 I:12-224,I:321-377                               --      1tb6I01 I:225-320,I:386-429                 -- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .......hhhhh...........----------........hhhhhhhhhhhhhhhhhhhhhhhh.......eeehhhhhhhhhhhhhh..hhhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhhhh...eeeeeeeeeee.....hhhhhhhhhhhh....eee....hhhhhhhhhhhhhhhhh..................eeeeeeeeee.......hhhhheeee.........eeeeeeeeeeeeeee.hhh.eeeeee.....eeeeeee.....hhhhhhhhhhhhhhhhhhhhheeeeeeeeee.eeeeeeeehhhhhhhh..hhhhh....................eeeeeeeeee....------..............eeee....eeeeeee....eeeeeeee..... Sec.struct. author
             SAPs(SNPs) (1) ---N------------TF--C----------------L-----C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R-----------------V----DCL-------C-TKGA-P-----------T--RT-D-LF- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V---------------------------------------------------------------------------------------------------------------------------------------------H--------L---ML------------------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------ SAPs(SNPs) (3)
                PROSITE (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     ------------------- PROSITE (2)
           Transcript 2 (1) Exon 2.3a  PDB: I:4-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                          Exon 2.4c  PDB: I:105-176 UniProt: 137-208                              Exon 2.5a  PDB: I:177-222 UniProt: 209-254    Exon 2.6b  PDB: I:223-353 UniProt: 255-385                                                                                         ---------------------Exon 2.8a  PDB: I:375-431 (gaps) UniProt: 407-464         Transcript 2 (1)
           Transcript 2 (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 2.7a             --------------------------------------------------------- Transcript 2 (2)
                1tb6 I    4 PVDICTAKPRDIPMNPMCIYRSP----------EQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEG------TAVVIAGRSLNPNRVCFKANRPFLVFIREVPLNTIIFMGRVANPCV  431
                                    13        23  |      -   |    43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373     |   -  |    393       403       413       423        
                                                 26         37                                                                                                                                                                                                                                                                                                                                                   379    386

Chain L from PDB  Type:PROTEIN  Length:43
 aligned with THRB_HUMAN | P00734 from UniProtKB/Swiss-Prot  Length:622

    Alignment length:43
                                   327       337       347       357   
          THRB_HUMAN    318 SEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYI  360
               SCOP domains d1tb6.1 L:,H: Thrombin                      SCOP domains
               CATH domains 1tb6L00 L:1R-14K                            CATH domains
               Pfam domains ------------------------------------------- Pfam domains
         Sec.struct. author .......hhhhhh...........hhhhh.....hhhhhhhh. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------- SAPs(SNPs)
                PROSITE (1) ------------------------------------------- PROSITE (1)
                PROSITE (2) ------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.8          ------------------------- Transcript 1 (1)
           Transcript 1 (2) -----------------Exon 1.9  PDB: L:1A-14K    Transcript 1 (2)
                1tb6 L   1R SEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYI  14K
                            ||||||||1I|||||||| 2        12  |||||14H|||
                           1R|||||||1I||||||||            14A||||||14J|
                            1Q|||||||1H|||||||             14B||||||14K
                             1P|||||| 1G||||||              14C||||||  
                              1O|||||  1F|||||               14D|||||  
                               1N||||   1E||||                14E||||  
                                1M|||    1D|||                 14F|||  
                                 1L||     1C||                  14G||  
                                  1K|      1B|                   14H|  
                                   1J       1A                    14I

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (2, 2)

CATH Domains (4, 5)

Pfam Domains (0, 0)

Gene Ontology (60, 68)

Asymmetric/Biological Unit(hide GO term definitions)

Chain H,L (THRB_HUMAN | P00734)

molecular function
	GO:0005509	calcium ion binding	Interacting selectively and non-covalently with calcium ions (Ca2+).
	GO:0008083	growth factor activity	The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0008233	peptidase activity	Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0005102	receptor binding	Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
	GO:0004252	serine-type endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
	GO:0008236	serine-type peptidase activity	Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
	GO:0070053	thrombospondin receptor activity	Combining with thrombospondin and transmitting the signal to initiate a change in cell activity.
biological process
	GO:0006888	ER to Golgi vesicle-mediated transport	The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
	GO:0006953	acute-phase response	An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007597	blood coagulation, intrinsic pathway	A protein activation cascade that contributes to blood coagulation and consists of the interactions among high molecular weight kininogen, prekallikrein, and factor XII that lead to the activation of clotting factor X.
	GO:0007166	cell surface receptor signaling pathway	A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
	GO:0044267	cellular protein metabolic process	The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
	GO:0071260	cellular response to mechanical stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
	GO:0042730	fibrinolysis	A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0050900	leukocyte migration	The movement of a leukocyte within or between different tissues and organs of the body.
	GO:0007275	multicellular organism development	The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
	GO:0048712	negative regulation of astrocyte differentiation	Any process that stops, prevents, or reduces the frequency, rate or extent of astrocyte differentiation.
	GO:0051918	negative regulation of fibrinolysis	Any process that stops, prevents, or reduces the frequency, rate or extent of fibrinolysis, an ongoing process that solubilizes fibrin, resulting in the removal of small blood clots.
	GO:0010544	negative regulation of platelet activation	Any process that decreases the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue.
	GO:0045861	negative regulation of proteolysis	Any process that stops, prevents, or reduces the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.
	GO:0017187	peptidyl-glutamic acid carboxylation	The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
	GO:0030168	platelet activation	A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
	GO:0030194	positive regulation of blood coagulation	Any process that activates or increases the frequency, rate or extent of blood coagulation.
	GO:0030307	positive regulation of cell growth	Any process that activates or increases the frequency, rate, extent or direction of cell growth.
	GO:0008284	positive regulation of cell proliferation	Any process that activates or increases the rate or extent of cell proliferation.
	GO:0032967	positive regulation of collagen biosynthetic process	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
	GO:1900738	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway	Any process that activates or increases the frequency, rate or extent of phospholipase C-activating G-protein coupled receptor signaling pathway.
	GO:0001934	positive regulation of protein phosphorylation	Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
	GO:2000379	positive regulation of reactive oxygen species metabolic process	Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.
	GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
	GO:0006508	proteolysis	The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
	GO:0030193	regulation of blood coagulation	Any process that modulates the frequency, rate or extent of blood coagulation.
	GO:0008360	regulation of cell shape	Any process that modulates the surface configuration of a cell.
	GO:0051480	regulation of cytosolic calcium ion concentration	Any process involved in the maintenance of an internal steady state of calcium ions within the cytosol of a cell or between the cytosol and its surroundings.
	GO:0010468	regulation of gene expression	Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
	GO:0014854	response to inactivity	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inactivity stimulus.
	GO:0009611	response to wounding	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
	GO:0006465	signal peptide processing	The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell.
cellular component
	GO:0005796	Golgi lumen	The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0005788	endoplasmic reticulum lumen	The volume enclosed by the membranes of the endoplasmic reticulum.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0031012	extracellular matrix	A structure lying external to one or more cells, which provides structural support for cells or tissues.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain I (ANT3_HUMAN | P01008)

molecular function
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0030414	peptidase inhibitor activity	Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
	GO:0002020	protease binding	Interacting selectively and non-covalently with any protease or peptidase.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004867	serine-type endopeptidase inhibitor activity	Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.
biological process
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0010951	negative regulation of endopeptidase activity	Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0010466	negative regulation of peptidase activity	Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins.
	GO:2000266	regulation of blood coagulation, intrinsic pathway	Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Visualization

Interactive Views

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		BMA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FUC	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GU0	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GU1	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GU2	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GU3	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GU4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GU5	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GU6	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GU8	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GU9	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MAN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MPD	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NDG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]
		BC6	[ RasMol ]	+environment [ RasMol ]
		BC7	[ RasMol ]	+environment [ RasMol ]
		BC8	[ RasMol ]	+environment [ RasMol ]
		BC9	[ RasMol ]	+environment [ RasMol ]
		CC1	[ RasMol ]	+environment [ RasMol ]
		CC2	[ RasMol ]	+environment [ RasMol ]
		CC3	[ RasMol ]	+environment [ RasMol ]
		CC4	[ RasMol ]	+environment [ RasMol ]
		CC5	[ RasMol ]	+environment [ RasMol ]
		CC6	[ RasMol ]	+environment [ RasMol ]
		CC7	[ RasMol ]	+environment [ RasMol ]
		CC8	[ RasMol ]	+environment [ RasMol ]
		CC9	[ RasMol ]	+environment [ RasMol ]
		DC1	[ RasMol ]	+environment [ RasMol ]
		DC2	[ RasMol ]	+environment [ RasMol ]
		DC3	[ RasMol ]	+environment [ RasMol ]
		DC4	[ RasMol ]	+environment [ RasMol ]
		DC5	[ RasMol ]	+environment [ RasMol ]
		DC6	[ RasMol ]	+environment [ RasMol ]
		DC7	[ RasMol ]	+environment [ RasMol ]
		DC8	[ RasMol ]	+environment [ RasMol ]
		DC9	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Ser H:36A - Pro H:37	[ RasMol ]

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (15, 36)

Sites (36, 36)

SS Bonds (8, 8)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (90, 90)

PROSITE Motifs (4, 4)

Exons (13, 14)

Sequences/Alignments

Classification and Annotation

SCOP Domains (2, 2)

CATH Domains (4, 5)

Pfam Domains (0, 0)

Gene Ontology (60, 68)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File